Tufton Capital Management’s Eli Lilly LLY Stock Holding History

Tufton Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.59M	Sell	5,698 -30	-0.5%	-$35.4K	1.13%	31
2026 Q2	$6.87M	Sell	5,728 -87	-1%	-$88.9K	1.15%	31
2026 Q1	$5.35M	Sell	5,815 -74	-1%	-$75K	0.97%	35
2025 Q4	$6.33M	Buy	5,889 +157	+3%	+$150K	1.11%	34
2025 Q3	$4.37M	Buy	5,732 +986	+21%	+$734K	0.78%	45
2025 Q2	$3.7M	Sell	4,746 -121	-2%	-$94K	0.7%	50
2025 Q1	$4.02M	Buy	4,867 +78	+2%	+$64.9K	0.77%	48
2024 Q4	$3.7M	Buy	4,789 +212	+5%	+$176K	0.7%	49
2024 Q3	$4.05M	Buy	4,577 +1,110	+32%	+$998K	0.76%	45
2024 Q2	$3.14M	Buy	3,467 +15	+0.4%	+$12K	0.61%	49
2024 Q1	$2.69M	Buy	3,452 +1,116	+48%	+$794K	0.53%	57
2023 Q4	$1.36M	Buy	2,336 +1,896	+431%	+$1.11M	0.29%	66
2023 Q3	$236K	Hold	440	–	–	0.05%	112
2023 Q2	$206K	Buy	+440	New	+$185K	0.04%	118

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Tufton Capital Management's LLY Position: Q3 2026 in Review

Tufton Capital Management reduced its Eli Lilly (LLY) stake by 0.52% in Q3 2026, selling an estimated $35.4K and leaving 5,698 shares worth $6.59M. The position accounts for 1.13% of the portfolio, ranked #31.

Tufton Capital Management first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. The position peaked at $6.87M in Q2 2026. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Tufton Capital Management held 5,698 shares of Eli Lilly worth $6.59M as of Q3 2026.
Tufton Capital Management sold 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
Eli Lilly made up 1.13% of Tufton Capital Management's portfolio in Q3 2026, its #31 holding.
Tufton Capital Management first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
Tufton Capital Management's Eli Lilly position peaked at $6.87M in Q2 2026.
3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Tufton Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.